Novedades seca.

Las novedades de nuestra empresa.

Expansion course in BeNeLux: seca conquers next fitness market

- At the end of a successful year, the signs are pointing to expansion at seca: the specialist for medically validated bioimpedance measuring devices for determining body composition is entering the up-and-coming fitness market in the BeNeLux countries.


Log4j security vulnerability - seca products are not affected.

- In connection with the latest findings about Log4J vulnerabilities, seca has conducted extensive analyses to ensure the security of our devices and thus the (data) security of our customers. The open source tool called Log4J is not used in any of our products. This means that none of our products are affected by the security vulnerabilities. In the development of our products we attach great importance to the highest security standards and will do our utmost to maintain them in the future, so that our partners can rely on us. If you have any further questions, please contact info@seca.com.


COVID-19: No se deben ignorar parámetros básicos como el peso, la altura y los datos vitales, especialmente en el caso de los grupos de riesgo

- La pandemia del COVID-19 plantea grandes retos para los médicos y los sistemas de salud en todo el mundo. En particular, las personas con afecciones preexistentes presentan un mayor riesgo de infecciones graves. Las publicaciones en revistas médicas y de organizaciones independientes indican que la medición exacta de los parámetros vitales puede desempeñar un rol importante en el tratamiento de los grupos de riesgo con COVID-19. La altura, el peso y los datos vitales como la presión sanguínea, la saturación de oxígeno, el pulso y la temperatura son, por ejemplo, importantes para la dosificación exacta de la medicación y el ajuste de los ventiladores. Adicionalmente, esta información ayuda en…


seca aumenta las capacidades de producción para la tecnología médica relevante para el sistema

El suministro de hospitales, departamentos de emergencia y prácticas médicas tiene la mayor prioridad

- En muchos países, las autoridades y las instituciones competentes han clasificado seca y su tecnología médica como sistema relevante para apoyar los sistemas de salud en la lucha contra la pandemia de COVID 19. Debido a la situación actual, la presión en salas de emergencia y hospitales es muy alta y la necesidad de tecnología médica cada vez es mayor. La compañía está manteniendo la producción y expandiendo las capacidades para atender mejor esta demanda y contribuir a la lucha contra el coronavirus.


A strong partner – in the time of Covid-19 too

We stand by you

- While the whole world is attempting to slow down the number of new infections with coronavirus, we are concentrating on protecting our employees and instituting measures to make sure our production in Hamburg remains fully operational. Our production site in Hangzhou has returned to 90 percent of production capacity since China ended its shutdown. That gives us hope and sends a positive signal to everyone. We take this opportunity to thank all our employees and partners whose support and engagement are keeping our products and service available to all who need them.


seca is awarded MDR certification

EU Medical Device Regulation successfully implemented three months before it fully comes into force

- As one of the first Med Tech companies in Europe, seca is the global market leader in medical measuring and weighing and has passed the official MDR (Medical Device Regulation) audit even before the new EU regulation comes into effect in May 2020. Three auditors from the Notified Body (TÜV-SÜD Product Service) analyzed and audited the seca quality management system in accordance with the MDR requirements for medical devices and assessed all of them as successfully met.


Global medical societies define reduced muscle mass as an independent criterion for diagnosis of malnutrition

Validated BIA from seca conforms to consensus on diagnostic methods

- The international societies ASPEN, ESPEN, FELANPE and PENSA established the Global Leadership Initiative in Malnutrition (GLIM) to build a worldwide consensus for diagnostic criteria for malnutrition. The consensus report published in September 2018 elevates reduced muscle mass to one of the decisive, independent evaluation criteria used in the diagnosis of malnutrition. seca welcomes this step, which the company sees as validation of its advocacy of improved diagnosis and treatment of malnutrition.


16th international branch: seca opens Benelux office

German medical technology company to build on successful projects in viable Benelux markets

- Right on the heels of the November opening of the seca | lietuva site, the market leader in medical measuring systems and scales has opened its 16th international subsidiary seca | benelux. The company sees great potential in the progressive healthcare sector in Benelux countries and opportunities for sales, particularly of its EMR-ready and digital measuring solutions.